Clarity Pharmaceuticals Ltd.ASX: CU6

First patient treated in the prostate cancer imaging trial

Apr 21, 2022 at 4:07 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment